Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells

Journal of Neurochemistry

Volumn 73, Issue 5, 1999, Pages 2009-2017

  Schumann, Gunter ^a   Huell, Michael ^a   Machein, Uwe ^a,c   Hocke, Gertrud ^b   Fiebich, Bernd L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Novartis GmbH   (Germany)

Author keywords

Acute phase proteins; Alzheimer's disease; Neuron; Phosphorylation; Rat hippocampal neurons; SH SY5Y cells

Indexed keywords

INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032736679     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.02009.x     Document Type: Article

References (59)

1. Abraham C. R., Selkoe D. J., and Potter H. (1988) Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., and Peschle C. (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating-factors) by normal human astrocytes in response to IL-1β and tumor-necrosis-factora. J. Immunol. 149, 2358-2366.
3. 2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
4. Bauer J., Ganter U., Abel J., Strauss S., Jonas U., Weiss R., Gebicke-Härter P., Volk B., and Berger M. (1993) Effect of interleukin-1 and interleukin-6 on metallothionein and amyloid precursor protein in human neuroblastoma cells. J. Neuroimmunol. 45, 163-174.
5. Billon N., van Grunsven L. A., and Rudkin B. B. (1996) The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13, 2047-2054.
6. Bonner W. M. and Laskey R. A. (1974) A film detection method for tritium-labeled proteins and nucleic acids in polyacrylamide gels. Eur. J. Biochem. 46, 83-88.
7. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B., and Mucke L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061-10065.
8. Chai Z., Gatti S., Tonatti C., Poli V., and Bartfai T. (1996) Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide of IL-1β: a study on IL-6 deficient mice. J. Exp. Med. 183, 311-316.
9. Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P., and Shuai K. (1997) Specific inhibition of STAT3 signal transduction by PIAS3. Science 278, 1803-1805.
10. Chung J., Uchida E., Grammer T. C., and Blenis J. (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol. Cell. Biol. 17, 6508-6516.
11. Daeipour M., Kumar G., Amaral M. C., and Nel A. E. (1993) Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF 10. J. Immunol. 150, 4743-4753.
12. Dajee M., Kazansky A. V., Raught B., Hocke G. M., Fey G. H., and Richards J. S. (1996) Prolactin induction of the alpha 2-macroglobulin gene in rat ovarian granulosa cells: STAT 5 activation and binding to the interleukin-6 response element. Mol. Endocrinol. 10, 171-184.
13. Darnell J. E. J. (1997) STATs and gene regulation. Science 277, 1630-1635.
14. Decker S. J. (1995) Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA. J. Biol. Chem. 270, 30841-30844.
15. Fiebich B., Biber K., Gyufko K., Berger M., Bauer J., and von Calker D. V. (1996) Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J. Neurochem. 66, 1426-1431.
16. Gadient R. A. and Otten U. (1994a) Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNA's in rat brain during postnatal development. Brain Res. 637, 10-14.
17. Gadient R. A. and Otten U. (1994b) Identification of interleukin 6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182, 243-246.
18. Gadient R. A. and Otten U. H. (1997) Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52, 379-390.
19. Ganter U., Strauss S., Jonas U., Weidemann A., Beyreuther K., Volk B., Berger M., and Bauer J. (1991) Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer β-amyloid precursor protein. FEBS Lett. 282, 127-131.
20. Giordano V., De Falco G., Chiari R., Quinto I., Pelicci P. G., Bartholomew L., Delmastro P., Gadina M., and Scala G. (1997) She mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J. Immunol. 158, 4097-4103.
21. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., and Hatanaka H. (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40, 445-452.
22. Hattori M., Abraham L. J., Northemann W., and Fey G. H. (1990) Acute-phase reaction induces a specific complex between hepatic nuclear protein and the interleukin 6 response element of the rat alpha 2-macroglobulin gene. Proc. Natl. Acad. Sci. USA 87, 2364-2368.
23. Heinrich P. C., Behrmann I., Müller-Newen G., Schaper F., and Graeve L. (1998) Interleukin-6-type signalling through the gp130/Jak/ STAT pathway. Biochem. J. 334, 297-314.
24. 2 macroglobulin gene. Mol. Cell. Biol. 12, 2282-2294.
25. Huell M., Strauss S., Volk B., Berger M., and Bauer J. (1995) Interleukin-6 is present in the early stages of plaque formation and is restricted to brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 89, 544-551.
26. Ihle J. N. and Kerr I. M. (1995) Jaks and STATs in signaling by the cytokine receptor superfamily. Trends Genet. 11, 69-74.
27. Kaptein A., Paillard V., and Saunders M. (1996) Dominant negative STAT3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271, 5961-5964.
28. Kishimoto T., Akira S., Narazaki M., and Taga T. (1995) Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
29. Lavenius E., Gestblom C., Johansson I., Nanberg E., and Pahlman S. (1995) Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth Differ. 6, 727-736.
30. Legler D. F., Loetscher M., Jones S. A., Dahinden C. A., Arock M., and Moser B. (1996) Expression of high-and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur. J. Immunol. 26, 753-758.
31. 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-κB. J. Neurochem. 67, 2039-2044.
32. Lieb K., Schaller H., Bauer J., Berger M., Schulze-Osthoff K., and Fiebich B. L. (1998) Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6. J. Neurochem. 70, 1577-1583.
33. Lütticken C., Wegenka U. M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A. G., Wilks A. F., Yasukawa K., Taga T., Kishimoto T., Barbieri G., Pellegrini S., Sendtner M., and Heinrich P. C. (1994) Association of transcription factor APRF and protein kinase Jak 1 with the interleukin-6 signal transducer gp 130. Science 263, 86.
34. Matsorakos G., Chrousos G. P., and Weber J. S. (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77, 1690-1694.
35. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
36. Meakin S. O. and MacDonald J. I. S. (1998) A novel juxtamembrane deletion in rat TrkA blocks differentiative but not mitogenic cell signal response to nerve growth factor. J. Neurochem. 71, 1875-1888.
37. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., and Kishimoto T. (1993) IL-6-induced homodimerization of gp 130 and associated activation of a tyrosine kinase. Science 260, 1808-1810.
38. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., and Kishimoto T. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.
39. Narazaki M., Witthuhn B. A., Yoshida K., Silvennoinen O., Yasukawa K., Ihle J. N., Kishimoto T., and Taga T. (1994) Activation of Jak2 kinase mediated by the interleukin-6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 91, 2285.
40. O'Farrell P. H. (1975) High resolution two dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021.
41. Oka T., Oka K., Hosoi M., and Hori T. (1995) Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692, 123-128.
42. Poli V., Mancini F. P., and Cortese R. (1990) IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643.
43. Poluha W., Poluha D. K., and Ross A. H. (1995) TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 5, 185-189.
44. Poluha W., Poluha D. K., Chang B., Crosbie N. E., Schonhoff C. M., Kilpatrick D. L., and Ross A. H. (1996) The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma. Mol. Cell. Biol. 16, 1335-1341.
45. Potempa L. A., Maldonado B. A., Laurent P., Zemel E. S., and Gewurz H. (1983) Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. Mol. Immunol. 20, 1165-1175.
46. Pumiglia K. M. and Decker S. J. (1997) Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94, 448-452.
47. Ringheim G. E., Burgher K. L., and Heroux J. A. (1995) Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol. 63, 113-123.
48. Sebire G., Emilie D., Wallon C., Hery C., Devergne O., Delfraissy J. F., Galanaud P., and Tardieu M. (1993) In vitro production of IL-6, IL-1β and tumor necrosis factor-α by human embryonic, microglial and neural cells. J. Immunol. 150, 1517-1523.
49. Stahl N., Boulton T. G., Farrugella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle S. N., and Yancopoulos G. D. (1994) Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6b receptor components. Science 263, 92.
50. Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., and Hilton D. J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921.
51. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., and Volk B. (1992) Detection of interleukin-6 and alpha-2-macroglobulin immunoreactivity in the cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
52. Vaillancourt R. R., Heasley L. E., Zamarripa J., Storey B., Valius M., Kazlaukas A., and Johnson G. L. (1995) Mitogen-activated protein kinase activation is insufficient for growth factor receptor-mediated PC12 cell differentiation. Mol. Cell. Biol. 15, 3644-3653.
53. Wegenka U. M., Buschmann J., Lutticken C., Heinrich P. C., and Horn F. (1993) Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13, 276-288.
54. Wegenka U. M., Lutticken C., Buschmann J., Yuan J., Lottspeich F., Muller-Esterl W., Schindler C., Roeb E., Heinrich P., and Horn F. (1994) The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol. Cell. Biol. 14, 3186-3196.
55. Wen Z., Zhong Z., and Darnell J. E. (1995) Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
56. Wood J. A., Wood P. L., Ryan R., Graff Radford N. R., Pilapil C., Robitaille Y., and Quirion R. (1993) Cytokine indices in Alzheimer's temporal cortex: no change in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
57. Wu Y. Y. and Bradshaw R. A. (1996a) Induction of neurite outgrowth by interleukin-6 is accompanied by activation of STAT3 signaling pathway in a variant PC12 cell (E2) line. J. Biol. Chem. 271, 13023-13032.
58. Wu Y. Y. and Bradshaw R. A. (1996b) Synergistic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC12 cells. J. Biol. Chem. 271, 13033-13039.
59. Yamada M. and Hatanaka H. (1994) Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643, 173-180.